 model updat result pt
messag turn solid ep yoy beat
revenu organ came consensu
manag mere maintain full year outlook despit upsid solid
perform increas convict compani turnaround track set
enter new phase acceler growth move rais
price target reiter buy rate
model still call adjust ep yoy total revenu
cc slightli prior sale estim
forecast ep sale cc longer term
continu see pathway compani post top-lin growth beyond
see deep dive note driven larg part acceler momentum knee
back recent product launch rosa cementless revis
rais pt reiter buy rate zimmer share current
trade ntm ep estim ntm ebitda well large-
cap med-tech averag view discount broader group
justifi given zimmer inferior top line growth trajectori vs see
current valuat gap excess expect share re-rat upward
compani continu show sign growth acceler rais price
target base multipl revis forward ntm
ep estim signific upsid potenti target current level assign
zimmer share buy rate
sector medic suppli devic
page analyst certif import disclosur
zimmer merger biomet made player hip knee wide
margin share global recon sale deal provid compani
ep accret scale also left zimmer sale come slow growth
market underperform late under-perform
exacerb past two year chronic manufactur issu suppli
constraint leav zimmer unabl servic client base effect recent remedi
effort address issu howev combin sever new key product
launch posit compani drive improv top line growth profit
move see zimmer knee busi particular
start meaning growth acceler driven compani rosa robot
surgeri system persona cementless implant believ improv knee growth
help boost overal compani top line gain lead signific multipl
expans process
zimmer share current trade ntm ep estim ntm
ebitda well large-cap med-tech averag view
discount broader group justifi given zimmer inferior top line growth trajectori
vs see current valuat gap excess expect share
re-rat upward compani begin show sign growth acceler
rais price target base unchang
multipl revis forward ntm ep estim signific upsid potenti
target current level assign zimmer share buy rate
downsid risk rate includ disappoint traction key new product
launch particular rosa robot surgeri system persona cementless knee
implant increas price and/or volum pressur ortho implant manufactur
failur complet resolv quality/suppli issu weigh zimmer result
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
